Immunological Implications in Experimental Myocardial Ischaemia: MPO (Myeloperoxidase) Expression Is Differentially Regulated by Beta-Blockers, While CD80 Expression Remains Unaffected

@inproceedings{Gasser2012ImmunologicalII,
  title={Immunological Implications in Experimental Myocardial Ischaemia: MPO (Myeloperoxidase) Expression Is Differentially Regulated by Beta-Blockers, While CD80 Expression Remains Unaffected},
  author={Robert P H Gasser and Sascha Paetzold and Eleonore Holzwart and Klemens Ablasser and Elisabeth Kraigher-Krainer and Ingeborg Friehs and Dirk von Lewinski and Burkert Pieske and Heinrich Maechler and A Trantiner-Yates and Tscheliessnig Kh and Harald Mangge and Sepp Porta and S. Gasser},
  year={2012}
}

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES

Myeloperoxidase as a biomarker in acute coronary syndrome: beware of the pitfalls.

  • Archives of medical research
  • 2011
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Pleiotropic effects of β-blockers upon subsets of the inflammatory cascade elicited by experimental ischemia in human myocardial tissue

E Kraigher-Krainer, E Holzwart, D von Lewinski
  • Abstract: ISHR World Congress
  • 2010
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Nebivolol, not atenolol inhibits the activation of T-cell immunity during experimental ischemia in human myocardial tissue

S Gasser, K Ablasser, R Gasser
  • Eur Heart J 2009;
  • 2009
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Effect of fibroblast growth factor NV 1 FGF on amputation and death : a randomised placebo - controlled trial of gene therapy in critical limb ischae

L Willhelmsen, G Berglund, D Elmfeldt
  • Lancet
  • 2011

PDK (pyruvate dehydrogenase kinase) is differentially regulated by beta-blockers in experimental myocardial hypoxia

S Gasser, PP Rainer, E Holzwart
  • Cardiovasc Res 2010;
  • 2010